Company Telo Genomics Corp. Toronto S.E.
Equities
TELO
CA87975M1095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- PTS | -.--% | -.--% | -.--% |
Apr. 10 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
Apr. 10 | Telo Genomics Corp. Receives Accreditation from College of American Pathologists | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 22-12-11 |
Sherif Louis
PSD | President | - | 14-12-31 |
Christopher Ross
DFI | Director of Finance/CFO | - | 21-03-31 |
Hugh Rogers
BRD | Director/Board Member | 44 | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 18-06-30 |
Director/Board Member | - | 22-02-02 | |
Guido Baechler
CHM | Chairman | 59 | 19-02-27 |
Hugh Rogers
BRD | Director/Board Member | 44 | 15-03-31 |
Sabine Mai
FOU | Founder | - | 11-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,309,933 | 67,327,029 ( 94.41 %) | 0 | 94.41 % |
Company contact information
Telo Genomics Corp.
MaRS Centre, South Tower 101 College Street
M5G 1L7, Toronto
+416-673-8487
http://www.telodx.comSector
1st Jan change | Capi. | |
---|---|---|
-16.10% | 11.41B | |
+67.65% | 3.81B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- TELO Stock
- TELO Stock
- Company Telo Genomics Corp.